Markets

BALANCE SHEET

You can view the balance sheet for the last 5 years.

Avience Biomedicals Ltd.

Jul 27 NSE 259.50( -0.25 -0.10%)

Volume75000

Prev. Close
259.75

Open Price
268.95

Today's Low / High

256.50 268.95

Bid Price (Qty.)0.00 (0)

Offer Price (Qty.) 0.00 (0)

52 Wk Low / High

222.00 414.95

(₹ in Crs.)

Particulars	Mar 26	Mar 25	Mar 24
Months	12	12	12
Source Of Info (AR = Annual Report, PR = Press Release)	PR	AR	AR
FaceValue	10.00	10.00	10.00
No. of Equity Shares (in Lacs)	40.31	40.31	40.31

EQUITIES AND LIABILITIES
SHAREHOLDER'S FUNDS
Equity Share Capital	4.03	4.03	3.28
Total Share Capital	4.03	4.03	3.28

Reserves and Surplus	27.38	18.75	2.93
Total Reserves and Surplus	27.38	18.75	2.93
Total Shareholders Funds	31.41	22.78	6.21

NON-CURRENT LIABILITIES
Long Term Borrowings	13.23	9.85	7.28
Deferred Tax Liabilities [Net]	0.19	0.15	0.12
Long Term Provisions	0.16	0.24	0.22
Total Non-Current Liabilities	13.57	10.24	7.62

CURRENT LIABILITIES
Short Term Borrowings	15.71	12.31	7.85
Trade Payables	9.47	7.27	5.55
Other Current Liabilities	4.43	1.43	6.69
Short Term Provisions	3.35	2.50	0.74
Total Current Liabilities	32.96	23.51	20.82

Total Capital And Liabilities	77.94	56.52	34.65

ASSETS
NON-CURRENT ASSETS
Tangible Assets	15.92	12.99	10.12
Intangible Assets	0.14	0.00	0.00
Capital Work-In-Progress	12.85	4.62	0.03
Fixed Assets	28.91	17.61	10.15
Goodwill On Consolidation	0.00	0.14	0.14
Non-Current Investments	0.03	0.03	0.03
Deferred Tax Assets [Net]	0.03	0.07	0.11
Long Term Loans And Advances	2.05	1.11	0.58
Other Non-Current Assets	0.38	0.38	0.60
Total Non-Current Assets	31.40	19.35	11.61


CURRENT ASSETS
Inventories	17.18	13.07	12.40
Trade Receivables	21.02	17.21	8.09
Cash And Cash Equivalents	2.93	4.94	0.36
Short Term Loans And Advances	5.26	1.86	2.14
OtherCurrentAssets	0.15	0.09	0.06
Total Current Assets	46.54	37.17	23.04

Total Assets	77.94	56.52	34.65

BONUS DETAILS
Bonus Equity Share Capital	0.00	0.75	0.75

NON-CURRENT INVESTMENTS
Non-Current Investments Unquoted Book Value	0.00	0.03	0.03

Particulars	Mar 26
Months	12
Source Of Info (AR = Annual Report, PR = Press Release)	PR
FaceValue	10.00
No. of Equity Shares (in Lacs)	40.31

EQUITIES AND LIABILITIES
SHAREHOLDER'S FUNDS
Equity Share Capital	4.03
Total Share Capital	4.03
Reserves and Surplus	27.38
Total Reserves and Surplus	27.38
Total Shareholders Funds	31.41
NON-CURRENT LIABILITIES
Long Term Borrowings	13.23
Deferred Tax Liabilities [Net]	0.19
Long Term Provisions	0.16
Total Non-Current Liabilities	13.57
CURRENT LIABILITIES
Short Term Borrowings	15.71
Trade Payables	9.47
Other Current Liabilities	4.43
Short Term Provisions	3.35
Total Current Liabilities	32.96
Total Capital And Liabilities	77.94
ASSETS
NON-CURRENT ASSETS
Tangible Assets	15.92
Intangible Assets	0.14
Capital Work-In-Progress	12.85
Fixed Assets	28.91
Goodwill On Consolidation	0.00
Non-Current Investments	0.03
Deferred Tax Assets [Net]	0.03
Long Term Loans And Advances	2.05
Other Non-Current Assets	0.38
Total Non-Current Assets	31.40
CURRENT ASSETS
Inventories	17.18
Trade Receivables	21.02
Cash And Cash Equivalents	2.93
Short Term Loans And Advances	5.26
OtherCurrentAssets	0.15
Total Current Assets	46.54
Total Assets	77.94
BONUS DETAILS
Bonus Equity Share Capital	0.00
NON-CURRENT INVESTMENTS
Non-Current Investments Unquoted Book Value	0.00